VIVAN Life Sciences Blog
Enter Sun Pharma for long term, says Sandeep Shenoy
Sandeep Shenoy of Pioneer Investcorp told CNBC-TV18, ” Sun Pharmaceutical Industries is a well-run company where the business models are not impeded, I don’t think the glitches make much of a problem on their business model. Any leader of a sector where there is a small stumble and you get a price correction, you should always use it for making an entry on a longer term basis because leadership position is garnered after many years of strategic planning and execution and that I don’t think is going to be seeded away by a few missteps. So, these are the kind of opportunities which one gets in all largecap or largecap leaders and one should capitalise on it.” At 09:15 hrs Sun Pharmaceutical Industries was quoting at Rs 886, up Rs 7.05, or 0.80 percent. It has touched an intraday high of Rs 886 and an intraday low of Rs 885.50.
